# Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome

> **NCT03630367** · PHASE4 · WITHDRAWN · sponsor: **Assiut University**

## Conditions studied

- Premature Birth

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** L-Carnitine 1G/5mL Injection

## Key facts

- **NCT ID:** NCT03630367
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-03
- **Primary completion:** 2020-09
- **Final completion:** 2020-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unavailability of the medication
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03630367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03630367, "Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03630367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*